Neuberger Berman Disrupters ETF

NBDSNeuberger BermanEquity
Expense ratio0.55%
Net assets$184.1M
Holdings32
Yield (TTM)0.33%
1 week+1.6%
1 month-3.1%
3 months+2.5%
6 months+10.1%
YTD+12.2%
1 year+2.9%
3 years*+24.6%

Total returns with distributions reinvested; * a year. Prices as of Oct 27, 2026 · filings through Aug 31, 2026 · page updated Nov 3, 2026

At a glance

NBDS charges 0.55% a year, below the 0.65% average of the 8 funds most like it (the 2nd cheapest of 9). It has $184.1M in assets, the 6th largest of that group; it paid 0.33% of its price in distributions over the past 12 months, annual. Over the past year it returned +2.9% with distributions reinvested (S&P 500: +11.5%), 6th of those 9 funds; over three years it returned +24.6% a year. Its ten largest positions make up 45.8% of the fund, out of 32 in all.

The short version

Neuberger Berman Disrupters ETF (NBDS) is an actively managed fund with no index to follow. It holds about 32 stocks that its managers see as disrupting existing markets or creating new ones, from NVIDIA and AMD to smaller drug developers. Its 0.55% expense ratio, after a fee waiver, is below the 0.65% average of similar growth funds. Over the year to October 27, 2026, it moved nearly twice as much as the market.

Price history

The interactive chart needs JavaScript.

NBDS +2.9% over the year to Oct 27, 2026, total return with distributions reinvested.

Prices through Oct 27, 2026. Total return: the price with distributions reinvested.

How it has behaved

Volatility (1 year)28.8%annualized; the S&P 500 is usually 15–20%
Worst drop (1 year)-24.0%3 years: -28.5% · all history: -28.8%
Beta vs S&P 5001.93moves more than the market
Sharpe ratio (1 year)-0.04return above cash per unit of risk
Since launch+12.0%a year over 4.5 years
52-week range$29.42 – $42.54
Last price $39.79 on Oct 27, 2026, 6.5% below the 52-week high · above its 200-day average ($37.44).
YTD1 yr3 yr5 yr10 yrSince start
NBDS official prospectus, to Dec 31, 2024—+18.35%———+8.15%
NBDS price data to Oct 27, 2026+12.2%+2.9%+24.6%——+12.0%
Multi-year figures are annualized total returns with distributions reinvested. "Official" figures are the SEC-standard returns from the fund's prospectus; the price-data row is computed from daily prices.
  • Over the year to Oct 27, 2026, NBDS returned +2.9%, 6th of 9 among similar funds.
  • Its worst full calendar year was 2024 (+18.0%); its best was 2023 (+38.5%).
  • The deepest fall in its price history was 28.8% (Apr 8, 2022 to Oct 14, 2022), recovered by Jul 13, 2023.
39%202318%202420%202512%2026*
39%202318%202420%202512%2026*
Calendar-year total returns from price data, distributions reinvested. * 2026 is year to date. From the prospectus: best quarter +15.64% (Mar 31, 2023), worst -7.19% (Sep 30, 2023).
Show as a table
YearPrice dataProspectus (official)
2026 (to date)+12.2%—
2025+19.6%—
2024+18.0%+18.35%
2023+38.5%+38.45%
2022—0.00%
2021—0.00%
2020—0.00%
2019—0.00%
2018—0.00%
2017—0.00%
2016—0.00%
2015—0.00%
2008 financial crisis
stocks fell Oct 9, 2007 – Mar 9, 2009
Before this security existed
2020 COVID crash
stocks fell Feb 19, 2020 – Mar 23, 2020
Before this security existed
2022 bear market
stocks fell Jan 3, 2022 – Oct 12, 2022
Before this security existed

Dividends and income

Yield (last 12 months)0.33%distributions ÷ price
Paid in the last 12 months$0.13per share, split-adjusted
How oftenannual 
Latest payment$0.1300Dec 19, 2025
$0.132025
$0.132025
Distributions per share by calendar year, adjusted for a share split. * 2026 to Oct 27, 2026.
Show as a table
YearPer shareChange
2025$0.1300
Distributions through Oct 27, 2026.

What's inside

As of Aug 31, 2026, the fund held 32 securities; the ten largest made up 45.77% of assets, and 2.65% sat in cash and money-market holdings.

HoldingWeight
NVIDIA Corp7.43%
Definium Therapeutics Inc4.96%
Advanced Micro Devices Inc4.86%
Snowflake Inc4.76%
Protagonist Therapeutics Inc4.45%
Glaukos Corp4.10%
ASML Holding NV4.02%
Constellation Energy Corp3.85%
Shopify Inc3.72%
Monolithic Power Systems Inc3.61%
Robinhood Markets Inc3.59%
ServiceNow Inc3.26%
Broadcom Inc2.84%
HEICO Corp2.84%
Spotify Technology SA2.83%

By country

United States 79.07%Canada 8.69%Netherlands 4.02%Luxembourg 2.83%United Kingdom 1.5%

By asset type

Stocks 97.37%

By sector

Technology26.8%
Consumer discretionary6.5%
Financials5.8%
Industrials4.3%
Utilities3.8%
Other companies2.6%
Communication services2.3%
Not classified47.9%
Sectors of the companies held, for the 52.1% of the fund in companies that have a stock page here; other holdings and cash aren't classified. Source: N-PORT holdings report as of Aug 31, 2026. Cash, money-market funds and derivatives are shown separately from the securities list.

What changed recently

  • Over the three months to Aug 31, 2026, investors added a net $150.4M (creations minus redemptions, per the N-PORT report).
  • Monthly total returns reported for that quarter: +3.26%, -8.56%, +4.73%.

How it works

NBDS does not track an index. Neuberger Berman's portfolio managers pick the stocks. They put at least 80% of assets into a concentrated portfolio of "disrupters": US and foreign companies, including some in emerging markets, that they believe are upending existing markets or creating new ones. Examples in the prospectus include cloud computing, artificial intelligence, robotics, autonomous driving, financial technology and blood-based cancer tests. Companies are typically worth more than $500 million when the fund buys them.

The managers study each company's growth potential, earnings estimates and management. They also look at how the stock price compares with long-term cash flow growth, and at free cash flow (cash left after running and investing in the business). They weigh industry leadership and side businesses that could add value. Environmental, social and governance factors count where they matter financially, but this is not a sustainable fund.

The prospectus sets no weighting formula or rebalancing schedule. Position sizes reflect the managers' judgment. They may sell when a stock hits a target price, when the business disappoints or when better ideas appear. The prospectus reports portfolio turnover of 34%, meaning roughly a third of the portfolio changes over a year. The fund is non-diversified, so it can hold fewer, larger positions, and it concentrates in technology and communication services. As of August 31, 2026, it held 32 stocks and no derivatives.

What it really costs

  • NBDS charges 0.55% a year, versus an average of 0.65% for the similar funds below (2nd of 9, cheapest first).
  • Of that, 0.65% is the management fee; the rest covers other fund expenses.
  • The fee includes a 0.1% waiver from the adviser, which may end.
  • Using the prospectus's standard example, $10,000 invested would cost about $56 in the first year and $801 over 10 years (assuming a 5% annual return).
Cost of $10,000 (SEC example)1 yr3 yrs5 yrs10 yrs
NBDS$56$198$352$801
SEC standard example: $10,000 invested, 5% annual return, shares sold at the end of each period.

In a retirement portfolio

RoleSatellite (higher risk)

A concentrated, actively managed growth fund that has moved nearly twice as much as the market fits as a small add-on to a diversified core.

NBDS could add concentrated growth exposure alongside broad, diversified funds. It launched on April 6, 2022, so it has no record from the 2008 or 2020 crashes. Its deepest drop, 28.8%, ran from April 8 to October 14, 2022. It recovered by July 13, 2023, about nine months after the low. Every full calendar year since has been a gain. Still, it fell 24% at one point in the year to October 27, 2026, and its one-year beta of 1.93 means it moved nearly twice as much as the market. Selling in a slump could lock in steep losses. The 0.33% yield, paid once a year, offers little income. In the SEC's standard example, costs come to $56 for the first year on $10,000. Past results don't predict the future, and a plan should look at the whole portfolio, not one fund.

Planning to live on your savings? See whether your whole plan holds up, with your real accounts, taxes and Social Security, in ReadyAimRetire.
Run my plan →

Who it may suit — and who should look elsewhere

May suit

  • Investors who want a small, actively picked slice of about 32 stocks in AI chips, cloud software, biotech and medical devices.
  • Cost-conscious buyers of active growth funds: its 0.55% expense ratio ranks second-lowest of nine similar funds compared.
  • Long-horizon investors who can sit through drops like its 28.8% fall in 2022 without needing to sell shares.

Look elsewhere if

  • Retirees seeking income: the yield was 0.33% as of October 27, 2026, paid just once a year.
  • Anyone wanting broad diversification: the fund is non-diversified, and its top 10 holdings made up 45.8% of assets as of August 31, 2026.
  • Investors who want a long track record: it launched in April 2022 and has no history through the 2008 or 2020 crashes.

Close alternatives

Matched by holdings overlap from the latest N-PORT reports.

FundOverlapCostNet assets1 yr3 yr
NBDS this fund—0.55%$184.1M+2.9%+24.6%
FFOG Franklin Focused Growth ETF FOCUSED GROWTH …26%0.55%$311.7M-0.4%—
ILDR First Trust Innovation Leaders ETF26%0.75%$324.2M+11.0%+33.7%
AIFD TCW Artificial Intelligence ETF25%0.75%$125.3M+33.8%—
PJFG PGIM Jennison Focused Growth ETF24%0.75%$140.3M+3.6%+25.2%
PGRO Putnam Focused Large Cap Growth ETF24%0.56%$212.1M+3.1%+24.6%
HFGO Hartford Large Cap Growth ETF23%0.59%$200.9M+2.5%+27.0%
TSEL Touchstone Sands Capital US Select Growth E…22%0.67%$83.5M-9.4%—
Net assets from each fund's latest N-PORT or annual report where available. Returns through Oct 27, 2026.

Questions investors ask

Is NBDS good for retirement?

It is more likely to fit as a small, higher-risk part of a retirement portfolio than as a core holding. NBDS holds about 32 growth stocks. Its yield was just 0.33% as of October 27, 2026, and its one-year beta of 1.93 means it moved nearly twice as much as the market. It fell 28.8% in 2022 and recovered by July 2023. Someone who may need to sell in a downturn could end up selling after a steep drop.

What stocks are in NBDS?

As of August 31, 2026, NBDS held 32 companies, and its top 10 made up 45.8% of assets. The largest were NVIDIA (7.4%), Definium Therapeutics (5.0%), Advanced Micro Devices (4.9%), Snowflake (4.8%), Protagonist Therapeutics (4.4%), Glaukos (4.1%) and ASML (4.0%). About 79% was in US companies and 8.7% in Canadian ones. The mix spans chips, software, biotech and medical devices, plus Constellation Energy and Shopify.

What is the NBDS expense ratio?

NBDS charges 0.55% a year, according to its prospectus filed December 12, 2025. That is a 0.65% management fee minus a 0.10% fee waiver. Similar growth funds averaged 0.65%, and NBDS ranked second-lowest on cost of the nine funds compared. In the SEC's standard example, $10,000 earning 5% a year would cost about $56 after one year, $352 after five years and $801 after ten.

Does NBDS pay dividends?

Yes, but very little. NBDS pays once a year. Its trailing 12-month yield was 0.33% as of October 27, 2026, or about $0.13 per share. That is typical of a fund built around fast-growing companies, which usually reinvest their profits instead of paying them out. Investors who rely on portfolio income would get almost nothing here. The fund's appeal rests on price growth, which is never guaranteed.

NBDS vs ILDR: what's the difference?

Both own innovation-focused growth stocks, and about 26% of their holdings overlapped in their latest N-PORT reports. NBDS is cheaper: 0.55% a year, compared with 0.75% for First Trust Innovation Leaders ETF (ILDR). ILDR has done better, though. As of October 27, 2026, it returned 33.7% a year over three years, against 24.6% for NBDS, and 11% over one year, against 2.9%. As of August 31, 2026, ILDR had about $324 million in net assets and NBDS about $184 million.

Sources

  • 485BPOS prospectus (risk/return XBRL), filed Dec 12, 2025 — SEC EDGAR
  • N-PORT holdings report, filed Oct 28, 2026 — SEC EDGAR
  • Prices: daily prices and distributions through Oct 27, 2026

For education only, not investment advice. Past performance does not predict future results.